Skip to content
Subscriber Only

Pfizer Reaches Safety Milestone for Covid Vaccine, CEO Says

  • Drugmaker now preparing to seek FDA emergency authorization
  • Company previously said shot was 90% effective against Covid
Albert Bourla

Albert Bourla

Photographer: Zach Gibson/Bloomberg
Updated on

Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its Covid-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.

Speaking at a virtual conference hosted by the New York Times on Tuesday, Bourla said the company was preparing to submit its data to the U.S. Food and Drug Administration. Last week, Pfizer and its partner BioNTech SE reported that an interim analysis showed their experimental vaccine was more than 90% effective in preventing symptomatic cases of Covid-19.